Melanoma is much deadlier when it appears on the scalp or neck than somewhere else on the body, according to a study published Monday.
... following a biopsy. A positive S-100 stain indicates that the tumor is most likely to be a melanoma. Depending on the outcome of the dissemination studies, a surgical resection has to be performed. It ...
... high levels of B-Raf activity due to the mutation prevents the cells from becoming a melanoma. It is only when the Akt3 protein is present in those cells and communicates with B-Raf that it lower ...
... a compound that can weaken the tumor by targeting a protein expressed on the surface of a melanoma cell. When chemotherapy was applied to the tumor in this weakened state it was much more effective ...
... cancer. An unanswered question, however, is why some people are more likely to develop melanoma than others. Despite years of research and clinical development, melanoma incidences continue to rise ...
... , Heinrich and colleagues studied 129 samples gathered from people with different types of melanoma and found that there is a high rate of mutations in these cancers.
“This means that if we can find ...
... research from the Oregon Health and Science University Cancer Institute about mutations in melanoma may bring a wellspring of hope to many patients. Researchers have discovered that there are several ...
... the therapy as part of this study. All had been diagnosed with regionally advanced, in-transit melanoma, characterized by cancerous growths that appear and spread mainly on the limbs. This type of ...
Disabling a protein frequently found in melanoma tumours may make the cancer more vulnerable to chemotherapy, according to a pilot study led by researchers in the Duke Comprehensive Cancer Centre...
... line with the findings of related studies in Europe and the United States, the high risk for melanoma stood out as novel. "This study is, to our knowledge, the first to report an increased risk of ...
CHICAGO (Reuters) - When they work, new melanoma treatments that enlist the help of the immune system to attack tumors can have a stunning effect, in some cases arresting the deadly skin cancer for ...
... molecule inhibitor reduced both endogenous and drug-induced resistance to chemotherapy in a mouse model of melanoma. The NF-ºB pathway is often active in human cancers and promotes resistance to ...
... know the results of genetic tests confirming they have inherited an increased risk of developing melanoma, they follow skin cancer screening recommendations more proactively—much like those who have ...
... and radiation.
The patient in the journal report was one of nine patients with metastatic melanoma who were being treated in a recently completed clinical trial to test dose- escalation of ...
... people know the results of genetic tests confirming they have inherited an increased risk of developing melanoma, they follow skin cancer screening recommendations more proactively -- much like those ...
